Stay updated with breaking news from Melanoma Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Marengo Therapeutics, Inc., a company pioneering novel therapeutics targeting the T cell receptor (TCR) Vβ to selectively activate the right T...
Disruptions from the COVID-19 pandemic have affected every area of health care. A new study published in the American Academy of Dermatology found that more melanomas in advanced stages and
COVID-19 delays caused skin cancer patients to get their diagnosis later which often lead to more severe cancers.
COVID-19 delays caused skin cancer patients to get their diagnosis later which often lead to more severe cancers.
COVID-19 delays caused skin cancer patients to get their diagnosis later which often lead to more severe cancers.